Related Experiment Video
Updated: Jun 5, 2026

The Portable Chemical Sterilizer (PCS), D-FENS, and D-FEND ALL: Novel Chlorine Dioxide Decontamination Technologies for the Military
Published on: June 29, 2014
Pneumonia-associated microbial species and stabilized chlorine dioxide-containing oral care products
Hadeel Ayoub1,2, Charu Sharma3, Richard L Gregory3
1Department of Biomedical Sciences and Comprehensive Care, School of Dentistry, Indiana University, Fort Wayne, IN.
Background:
This study evaluated the antifungal and antibacterial effects of stabilized chlorine dioxide-containing oral care products against yeast and bacterial species associated with pneumonia.
Methods:
Six yeast species (Candida albicans, Candida glabrata, Cryptococcus neoformans, Candida dubliniensis, Candida krusei, Candida tropicalis) and 5 bacterial species (Streptococcus pneumoniae, Klebsiella pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa) were grown in Sabouraud dextrose broth and brain-heart infusion media, respectively, overnight. Each microorganism was treated with individual chlorine dioxide-containing ClōSYS (Rowpar Pharmaceuticals) products (Silver Multi-Benefit Fluoride Mouthwash, Sensitive Fresh Breath Mouthwash, Ultra Sensitive Mouthwash, Oral Spray, Silver Toothpaste, Sensitive Toothpaste, Fluoride-free Toothpaste) at serial dilutions. Chlorhexidine gluconate (0.12%) mouthrinse and water were positive and negative controls, respectively. Treated species were grown overnight. Minimum inhibitory concentration (MIC) was evaluated. Five microliters of each culture were transferred to blood agar plates incubated overnight, and minimum fungicidal concentration (MFC) and minimum bactericidal concentrations (MBC) were evaluated.
Results:
All undiluted products produced antifungal effects against tested yeast species. Similarly, antibacterial effects were observed for all products except for S pneumoniae and H influenzae, which were resistant to killing by some products. All tested products produced fungistatic or bacteriostatic effects against tested fungal or bacterial species. Different concentrations of each product are required to produce MIC, MFC, and MBC for each species tested. Some species required an equal or higher MIC than MFC and MBC.
Conclusions:
Stabilized chlorine dioxide-containing ClōSYS oral care products exhibit antifungal and antibacterial effects against common yeast and bacterial species associated with pneumonia.
More Related Videos
07:07Controlled-release of Chlorine Dioxide in a Perforated Packaging System to Extend the Storage Life and Improve the Safety of Grape Tomatoes
Published on: April 7, 2017
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Microbiota of the Respiratory Tract
Atypical Pneumonia
Chemical Agents for Microbial Control
The Oral Microbiota